Primary Carnitine Deficiency as a Treatable Cause of Heart Failure in Young Patients
Meral Kayıkçıoğlu, Sema Kalkan Uçar(Ege University), Evrim Şimşek, Benay Özbay(University of Pittsburgh Medical Center), Selen Bayraktaroğlu(Ege University), Ebru Canda(Ege University), Burcu Yağmur(Ege University)
Cited by 4
Related Papers
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
|European Heart Journal|2023|329
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia
|European Heart Journal Supplements|2016|101
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy
|Atherosclerosis Supplements|2015|84
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire
|Genetics in Medicine|2022|64